JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Notification Letter and Reply Form For Registered Holders

Notification Letter and Reply Form For Registered Holders

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FINANCIAL PRODUCTS

DISCLOSEABLE TRANSACTION SUBSCRIPTION OF FINANCIAL PRODUCTS

ANNOUNCEMENT ON RECEIPT OF GOVERNMENT GRANTS

ANNOUNCEMENT ON RECEIPT OF GOVERNMENT GRANTS

Final dividend in cash for the year ended December 31, 2024

Final dividend in cash for the year ended December 31, 2024

CLARIFICATION ANNOUNCEMENT REGARDING DISTRIBUTION OF CASH DIVIDEND

CLARIFICATION ANNOUNCEMENT REGARDING DISTRIBUTION OF CASH DIVIDEND

Final dividend in cash for the year ended December 31, 2024

Final dividend in cash for the year ended December 31, 2024

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top